Severe acute respiratory symptoms and suspected SARS again 2020

Hon, Kam Lun; Leung, Karen Ka Yan

doi:10.12809/hkmj208375

Cited by 8 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The infection is generally very mild in children, and 39.6% were asymptomatic. This phenomenon is consistent with our experience with SARS 17 years ago, when most of the infected children also had mild clinical manifestations [10,11]. The Chinese mainland also has reported mortality and morbidity of pediatric COVID-19 cases and has concluded that the disease was generally mild [10,12].…”

supporting

confidence: 89%

Pediatric COVID-19: what disease is this?

Hon¹,

Leung²

2020

World J Pediatr

View full text Add to dashboard Cite

supporting

confidence: 89%

Pediatric COVID-19: what disease is this?

Hon¹,

Leung²

2020

World J Pediatr

View full text Add to dashboard Cite

“…With the alertness in personal hygiene and mass mask-wearing behavior due to SARS, the incidence of influenza and respiratory viral diseases was much reduced in 2003. 21 Out of all public health policies available today, influenza vaccination is a low-hanging fruit and should be actively encouraged. Given the relatively low influenza vaccination rate in Hong Kong (Table 1), healthcare professionals should continue to promote the importance of these safe and reliable interventions, and dismiss the misinformation and fallacies in the general public.…”

Section: Discussionmentioning

confidence: 99%

From influenza to COVID‐19 vaccinations: Counselling anxious parents about deaths following influenza immunizations in Korea

Hon¹,

Leung²

2021

Pediatric Pulmonology

View full text Add to dashboard Cite

To the Editor, Hong Kong citizens and anxious parents are astonished by the news that over 80 deaths have been reported following influenza immunizations in Korea, while some adverse events were also brought to the public's attention in Taiwan. 1 In Korea, the vaccine providers are believed to include domestic firms such as GC Pharma, SK Bioscience, Korea Vaccine, and Boryung Biopharma Co Ltd, a unit of Boryung Pharm Co Ltd, along with Sanofi which is headquartered in France. 2 The reports raised yet further concerns amongst the general public after the Singapore Ministry of Health advised temporary cessation for the use of two vaccines, one of which is used in Hong Kong. This episode could become an international crisis as the annual winter surge of influenza is just around the corner and raise serious public concerns. We analyze and search the literature to provide some facts which can help address these questions and further discuss the role of vaccination in combating influenza and COVID-19 from a public health perspective.

show abstract

“… 1,67 Health organizations and authorities should provide consistent definitions for index surveillance, epidemiological and prognostication studies, and refrain from the temptation of coining unnecessary new terminology to describe essentially the same conditions when outbreaks of severe respiratory infection occurs 13,65 . Travel or contact history is pivotal in formulating management protocol during any outbreak when the pathogen is not initially clear 2,68 . History of travel or contact provide important clues to emerging infections as evidenced during coronavirus outbreaks in 2003 and 2012, swine influenza pandemic in 2009 as well as the avian influenza outbreak in 2013.…”

Section: Similarities and Differences Of Sars Mers And Covid‐19mentioning

confidence: 99%

Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS

Hon¹,

Leung²,

Leung

et al. 2020

Pediatric Pulmonology

View full text Add to dashboard Cite

Many respiratory viral infections such as influenza and measles result in severe acute respiratory symptoms and epidemics. In the spring of 2003, an epidemic of coronavirus pneumonia spread from Guangzhou to Hong Kong and subsequently to the rest of the world. The WHO coined the acronym SARS (severe acute respiratory syndrome) and subsequently the causative virus as SARS‐CoV. In the summer of 2012, epidemic of pneumonia occurred again in Saudi Arabia which was subsequently found to be caused by another novel coronavirus. WHO coined the term MERS (Middle East respiratory syndrome) to denote the Middle East origin of the novel virus (MERS‐CoV). In the winter of 2019, another outbreak of pneumonia occurred in Wuhan, China which rapidly spread globally. Yet another novel coronavirus was identified as the culprit and has been named SARS‐CoV‐2 due to its similarities with SARS‐CoV, and the disease as coronavirus disease‐2019. This overview aims to compare and contrast the similarities and differences of these three major episodes of coronavirus outbreak, and conclude that they are essentially the same viral respiratory syndromes caused by similar strains of coronavirus with different names. Coronaviruses have caused major epidemics and outbreaks worldwide in the last two decades. From an epidemiological perspective, they are remarkably similar in the mode of spread by droplets. Special focus is placed on the pediatric aspects, which carry less morbidity and mortality in all three entities.

show abstract

Severe acute respiratory symptoms and suspected SARS again 2020

Cited by 8 publications

References 7 publications

Pediatric COVID-19: what disease is this?

Pediatric COVID-19: what disease is this?

From influenza to COVID‐19 vaccinations: Counselling anxious parents about deaths following influenza immunizations in Korea

Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS

Contact Info

Product

Resources

About